Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Highlights • Only 30% of advanced lung cancer patients are eligible for immunotherapy trials. • Real-world patients on immunotherapy have shorter survival than trial participants. • Rationalising trial entry criteria doubles the proportion of trial-typical patients. • Novel trials need broader entry criteria to improve their generalizability.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
